
Loading, please wait...

Loading, please wait...

Johnson & Johnson recently expanded its surgical vision portfolio in India with the official launch of the TECNIS Odyssey IOL. This advanced technology offers a full visual range, allowing cataract patients to see clearly across all distances. Consequently, patients can enjoy continuous vision from near to far without relying heavily on spectacles. The introduction of this lens specifically addresses the rising prevalence of age-related vision impairment in the country. Therefore, surgeons now have a more robust tool to improve patient outcomes during lens replacement procedures.
The TECNIS Odyssey IOL utilizes a proprietary freeform diffractive profile to optimize visual quality. This innovative design significantly enhances tolerance to residual refractive errors. According to clinical data, approximately 94% of patients reported satisfaction with their vision without glasses. Furthermore, about 93% of patients achieved complete spectacle independence across all distances. Additionally, the lens maintains high image contrast, which is crucial for daily tasks. Surgeons can now deliver reliable results for patients seeking a more active lifestyle after surgery.
Low-light performance remains a critical concern for many cataract patients. Fortunately, the new lens provides superior contrast sensitivity compared to traditional trifocal options. Specifically, 92% of patients expressed satisfaction when viewing steps or curbs at night. This benefit stems from the advanced optics that minimize visual disturbances like glares and halos. Moreover, the lens replicates the optics of the natural eye to ensure high-definition clarity. Because of these advancements, the platform marks 25 years of innovation in intraocular lens technology.
Currently, an estimated 94 million individuals in India over age 50 suffer from vision impairment. Most of these cases involve cataracts or progressive presbyopia. Since these conditions are natural parts of aging, the demand for effective correction continues to grow. Full visual range lenses offer a unique opportunity to correct these issues during a single surgical procedure. Thus, the expansion of the TECNIS portfolio helps meet the diverse needs of the aging population. By providing precise vision at every distance, J&J strengthens its commitment to global eye health.
Q1: What is the main benefit of the TECNIS Odyssey IOL?
The lens provides a full range of continuous vision, allowing patients to see clearly at near, intermediate, and far distances, often eliminating the need for glasses.
Q2: How does the lens perform in low-light environments?
It offers best-in-class image contrast and low-light performance, enabling patients to navigate safely and see clearly in dim conditions or at night.
Q3: Who is the ideal candidate for this intraocular lens?
Patients undergoing cataract surgery who also suffer from presbyopia and desire a high level of spectacle independence are typically ideal candidates.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Johnson & Johnson launched the TECNIS Odyssey IOL in India, a full visual range lens providing clear sight at all distances for cataract surgery patients....
6 months ago

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today